Literature DB >> 35484064

Reply: Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.

Armando Flores-Rebollar1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35484064      PMCID: PMC9040472          DOI: 10.1016/j.eimce.2022.03.005

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


× No keyword cloud information.
Dear Editor, Yasri and Wiwanitki's letter on my case report speculates as to the association between the COVID-19 vaccination, blood hyperviscosity and thyroid dysfunction. No pathophysiological relationship between hyperviscosity and "aberrant thyroid function" has been reported. False thyroid hormone test results due to blood hyperviscosity should not be confounded with thyroid dysfunction. Hyperviscosity caused by acellular components (proteins), which may be monoclonal or polyclonal, are a known cause of potential interference in thyroid immunoassays. These correspond to uncommon entities including: Waldenström's macroglobulinaemia, cryoglobulinaemia and multiple myeloma, as well as rheumatic diseases associated with high rheumatoid factor levels. Paraprotein interference in immunoassays used to measure thyroid hormone and thyroid-stimulating hormone (TSH) levels has been extensively and specifically studied; although false results are mostly reported in total thyroid hormone levels,3, 4, 5, 6 any immunoassay used may be prone to interference. However, such interference is recognisable and does not indicate any thyroid function abnormality.

Ethics

All the procedures performed in the course of this retrospective study were carried out in accordance with institutional and national research committee ethical standards, and the study was conducted in accordance with World Health Organization (WHO) standards for biomedical and scientific research in humans. Case reports do not require independent ethics committee approval. Informed consent was obtained from and signed by the study participant.

Funding

This study received no specific funding from public, private or non-profit organisations.

Conflicts of interest

The author has no conflicts of interest to declare.
  5 in total

1.  Circulating thyroid hormones in a patient with hyperviscosity syndrome.

Authors:  E Tamagna; J Hershman; B N Premachandra
Journal:  Clin Chim Acta       Date:  1979-04-16       Impact factor: 3.786

2.  Interference in thyroid-stimulating hormone determination.

Authors:  Mauro Imperiali; Paola Jelmini; Biagio Ferraro; Franco Keller; Roberto della Bruna; Marco Balerna; Luca Giovanella
Journal:  Eur J Clin Invest       Date:  2010-06-07       Impact factor: 4.686

Review 3.  Interferences With Thyroid Function Immunoassays: Clinical Implications and Detection Algorithm.

Authors:  Julien Favresse; Maria-Cristina Burlacu; Dominique Maiter; Damien Gruson
Journal:  Endocr Rev       Date:  2018-10-01       Impact factor: 19.871

4.  The Prevalence of Euthyroid Hypertriiodothyroninemia in Newly Diagnosed Multiple Myeloma and its Clinical Characteristics.

Authors:  Qingrong Pan; Yeqing Zhang; Wenkai Zhang; Yanjin Hu; Zhe Chen; Aijun Liu; Guang Wang
Journal:  Endocr Pract       Date:  2020-12-13       Impact factor: 3.443

5.  [Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine].

Authors:  Armando Flores Rebollar
Journal:  Enferm Infecc Microbiol Clin       Date:  2021-11-18       Impact factor: 1.994

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.